Scott D. Studenberg - Concepedia

Author

Scott D. Studenberg

Also Known As

S D Studenberg, S Studenberg, S. D. STUDENBERG, S. D. Studenberg, S. Studenberg, S.D. Studenberg, Scott D. Studenberg, Scott Studenberg

Publications

675

Citations

H-Index

Concepts

All Affiliations

Research Triangle Park Foundation University of North Carolina at Chapel Hill GlaxoSmithKline (United Kingdom)

About

Scott D. Studenberg is an author at Research Triangle Park Foundation specializing in medicine, pharmacology, and health sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	101
2	Health Sciences	2	2	27
3	Biochemistry	2	2	52
4	Engineering	1	1	19
5	Allergy	1	1	39

Scott D. Studenberg

Publications

537

Citations

H-Index

Page 1

	Year	Citations
Role of P-Glycoprotein on the CNS Disposition of Amprenavir (141W94), an HIV Protease Inhibitor Joseph W. Polli, Jeanne L. Jarrett, Scott D. Studenberg, Pharmaceutical Research	1999	218
Preclinical Pharmacology and Pharmacokinetics of GW433908, a Water-Soluble Prodrug of the Human Immunodeficiency Virus Protease Inhibitor Amprenavir Eric S. Furfine, Christopher Baker, Michael Hale, Antimicrobial Agents and Chemotherapy	2004	98
Pharmacokinetics of GW433908, a Prodrug of Amprenavir, in Healthy Male Volunteers Christine Falcoz, J.M. Jenkins, Carole Bye, The Journal of Clinical Pharmacology	2002	60
Digoxin-like immunoreactivity eliminated from serum by centrifugal ultrafiltration before fluorescence polarization immunoassay of digoxin. Robert H. Christenson, Scott D. Studenberg, S Beck-Davis, Clinical Chemistry Digoxin-like ImmunoreactivityImmunocytochemical TechniqueAdded DigoxinImmunologyFluorescence Polarization Immunoassay	1987	39
Metabolic Disposition and Pharmacokinetics of [<sup>14</sup>C]‐Amprenavir, a Human Immunodeficiency Virus Type 1 (HIV‐1) Protease Inhibitor, Administered As a Single Oral Dose to Healthy Male Subjects Brian M. Sadler, Gregory E. Chittick, Ronald E. Polk, The Journal of Clinical Pharmacology	2001	22
Effects of Aerosolized Synthetic Surfactant, Atovaquone, and the Combination of These on Murine Pneumocystis carinii Pneumonia Walter T. Hughes, Elaine M. Sillos, Stephen W. LaFon, The Journal of Infectious Diseases	1998	20
A robotics-based liquid chromatographic assay for the measurement of atovaquone in plasma Scott D. Studenberg, Joseph D. Long, Jeffrey H. Woolf, Journal of Pharmaceutical and Biomedical Analysis EngineeringMedicineAnalytical ChemistryBiomedical EngineeringClinical Chemistry	1995	19
Impaired biliary excretion of acetaminophen glucuronide in the isolated perfused rat liver after acute phenobarbital treatment and in vivo phenobarbital pretreatment. Scott D. Studenberg, Kim L. R. Brouwer Journal of Pharmacology and Experimental Therapeutics	1992	18
Hepatic disposition of acetaminophen and metabolites Scott D. Studenberg, Kim L. R. Brouwer Biochemical Pharmacology HepatologyPharmacological StudyMedicineLiver PhysiologyToxicology	1993	16
Efficacy of treatment with the iron (III) complex of diethylenetriamine pentaacetic acid in mice and primates inoculated with live lethal dose 100 Escherichia coli. L. M. Molina, Scott D. Studenberg, Gerald Wolberg, Journal of Clinical Investigation Diethylenetriamine Pentaacetic AcidIron MetabolismNitric OxideImmunologyEscherichia Coli	1996	14

Page 1